Login or sign up
For business

Eikonizo Therapeutics

4.5· 11 reviews
Average ratingExcellent
4.5/ 5

Based on 11 reviews

555%
445%
30%
20%
10%
Ask AI

Ask AI about Eikonizo Therapeutics

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Elizabeth Woock
Reviews 1

Eikonizo Therapeutics is an excellent company to work with. Their website is user-friendly and provides a lot of helpful information. The team is knowledgeable and responsive, always ready to answer any questions or provide support. I highly recommend their services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Eikonizo Therapeutics

Eikonizo Therapeutics, Inc. was founded in October 2017 based on discoveries from Dr. Jacob Hooker’s academic lab (at MGH (Massachusetts General Hospital) and the Martinos Center for Biomedical Imaging) around novel small molecule design and human PET neuroimaging agents. ‘Eikonizo’ (ee-kuh-NEE-zo) is Greek for ‘envision’ or ‘imagine’. It captures their strategy to use PET imaging early in the drug discovery process to de-risk novel targets and lead therapeutic candidates, allowing us to envision an accelerated path to drug discovery and development. This is especially needed for brain diseases, where drug development is typically hampered by the inability to measure whether a drug has even gotten to the brain. They’re applying this approach in their lead project focusing on novel small molecule therapeutics for neurodegenerative diseases, such as Alzheimer’s Disease and ALS.